Information från ABG Sundal Collier

Här finner du information kring börsens mindre och medelstora bolag. Avsändare är ABG Sundal Collier, innehållet är inte skapat av placera.nu:s redaktion.

« Tillbaka

Catella - Q2 softer than expected, but underlying trends improving

20 augusti 2026

<a id="bm-comp-da36495d-3c2f-4add-9953-1b3e294910a4" name="bm-comp-da36495d-3c2f-4add-9953-1b3e294910a4" class="BMCustomAnchor"></a><table><tr><td bm-component-id="da36495d-3c2f-4add-9953-1b3e294910a4" style="vertical-align: top; width:100.000000%;"><ul><li>Q2 EBIT of SEK 8m, vs. ABGSC of SEK 26m and cons. SEK 15m</li><li>AUM of SEK 161bn bang in line, while transaction activity continues to improve</li><li>Negative consensus revisions to follow</li></ul></td></tr></table><a id="bm-comp-391a176d-27d4-4843-af64-ba3cce97e4d5" name="bm-comp-391a176d-27d4-4843-af64-ba3cce97e4d5" class="BMCustomAnchor"></a><table><tr><td bm-component-id="391a176d-27d4-4843-af64-ba3cce97e4d5" style="vertical-align: top; width:100.000000%;"><h3 class="bm-h3"><strong>Q2 EBIT SEK 8, vs. ABGSC at 26m &amp; consensus at 15m</strong></h3><p>The Q2&#8217;26 underlying EBIT improved by SEK 43m y-o-y whe adjusting for one-offs, and came in at SEK 8m, which was 18m below ABGSC and 7m below FactSet consensus. Looking at underlying development, the Investment Management segment delivered weaker than expected results in Q2, while Corporate Finance was more broadly in line.</p><h3 class="bm-h3"><strong>AUM of SEK 160.8 bn in Q2, bang in line with both ABGSC &amp; consensus forecast</strong></h3><p>Net sales in Q2 came in at SEK 400m (722m), which was 7% above ABGSC's forecast and 8% above consensus. Reported EBITDA came in at SEK 27m, 19m below both ABGSC and FactSet consensus. The AUM came in at SEK 160.8bn, up 1% q-o-q (SEK 159.8bn), which was bang in line with both ABGSC forecast and consensus. The slight increase of 1bn sequentially is driven by FX tailwind, offsetting both capital outflow and lowered valuations in the underlying portfolios.</p><h3 class="bm-h3"><strong>Negative cons. revisions to follow</strong></h3><p>We expect consensus to cut their &#8216;26e EBIT by ~1-3% mainly reflecting the Q1 and Q2 earnings shortfall in IM, while improving activity and solid AUM should limit revisions to 2027-&#8216;28. Regarding the SEK 100m share buyback program announced in Q1, Catella repurchased 2.5m shares during Q2 for c. SEK 52m, corresponding to 2.95% of total shares outstanding. Call at 10.00.</p></td></tr></table>pagebreak <a id="bm-comp-25bf0a90-358e-4677-83f4-eb5020e80888" name="bm-comp-25bf0a90-358e-4677-83f4-eb5020e80888" class="BMCustomAnchor"></a><table><tr><td bm-component-id="25bf0a90-358e-4677-83f4-eb5020e80888" style="vertical-align: top; width:100.000000%;"><table id="bm-img-67a197e9-5497-4941-a524-c9ef6c88602c" class="bm-img-table xslt-img-empty xslt-img-include"><tr><td><img bm-img-encrypt="67a197e9-5497-4941-a524-c9ef6c88602c" bm-img-original-height="565" bm-img-original-width="1277" bm-img-svg="image:image_upload/98226_3a20ce6c-e242-41d1-ba20-c7a6cc7ea2c7.svg" bm-img-width-hint="100%" id="bm-id-67a197e9-5497-4941-a524-c9ef6c88602c" src="https://abgsc.bluematrix.com/images/image_upload/98226_3a20ce6c-e242-41d1-ba20-c7a6cc7ea2c7_733.png" svg="/nas/web/clients/abgsc/images/image_upload/98226_3a20ce6c-e242-41d1-ba20-c7a6cc7ea2c7.svg" width="727" alt="" title="" /></td></tr></table></td></tr></table>

Senaste artiklar från alla bolag

Datum Titel Bolag Typ
2026-08-23 Catella - Signs of improvement, but delivery stil... Catella Analys
2026-08-23 Ogunsen - Some signs of stabilisation Ogunsen Analys
2026-08-21 Clavister - Strong quarter strengthens the outlook Clavister Analys
2026-08-21 Generic - Investing while growing Generic Analys
2026-08-21 Impact Coatings - A quarter driven by Coating Ser... Impact Coat.. Analys
2026-08-21 Skolon - Sweden profitability gains continue Skolon Analys
2026-08-21 I-tech - Strongest quarter on record I-tech Analys
2026-08-20 Tempest Security - Patrols below plan Tempest Sec.. Analys
2026-08-20 Tempest Security - Progress made but expectations... Tempest Sec.. Analys
2026-08-20 Ascelia Pharma - Still alive: Fighting to reverse... Ascelia Pharma Analys
2026-08-20 Clavister - Defence drives record quarter Clavister Analys
2026-08-20 Catella - Q2 softer than expected, but underlying... Catella Analys
2026-08-20 Generic - Volumes continue to grow Generic Analys
2026-08-19 SinterCast - Past the trough, but recovery pace u... SinterCast Analys
2026-08-19 Xplora Technologies - EBITDA -13% on soft senior ... Xplora Tech.. Analys
2026-08-19 SinterCast - Recovery vs H2'25 trough, but still ... SinterCast Analys
2026-08-18 OssDsign - Soft commercial momentum near-term OssDsign Analys
2026-08-18 OssDsign - Beat on EBIT on lower sales OssDsign Analys
2026-08-18 Donkey Republic - Riding with high cadence Donkey Repu.. Analys
2026-08-17 Lumi Gruppen - Adding up nicely Lumi Gruppen Analys